Igm Antibody And Thyroid
Thyroid Stimulating Hormone, intact and beta |
|||
| MBS607893-1mg | MyBiosource | 1mg | 760 EUR |
Monoclonal Laboratories manufactures the igm antibody and thyroid reagents distributed by Genprice. The Igm Antibody And Thyroid reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact igm antibody. Other Igm products are available in stock. Specificity: Igm Category: Antibody Group: And Thyroid
Emerin (Papillary Thyroid Carcinoma and EDMD Marker) |
||
| MyBiosource | 0.1mg(WithoutBSA&Azideat1mg/mL) | 405 EUR |
Emerin (Papillary Thyroid Carcinoma and EDMD Marker) |
||
| MyBiosource | 5x0.1mg(WithBSA&Azideat0.2mg/mL) | 1725 EUR |
Emerin (Papillary Thyroid Carcinoma and EDMD Marker) |
||
| MyBiosource | 5x0.1mg(WithoutBSA&Azideat1mg/mL) | 1725 EUR |
Emerin (Papillary Thyroid Carcinoma and EDMD Marker) |
||
| MyBiosource | 0.02mg(WithBSA&Azideat0.2mg/mL) | 230 EUR |
Emerin (Papillary Thyroid Carcinoma and EDMD Marker) |
||
| MyBiosource | 0.1mg(WithBSA&Azideat0.2mg/mL) | 405 EUR |
Emerin (Papillary Thyroid Carcinoma and EDMD Marker) |
||
| MyBiosource | 0.1mg(WithoutBSA&Azideat1mg/mL) | 405 EUR |
Emerin (Papillary Thyroid Carcinoma and EDMD Marker) |
||
| MyBiosource | 5x0.1mg(WithBSA&Azideat0.2mg/mL) | 1725 EUR |
Emerin (Papillary Thyroid Carcinoma and EDMD Marker) (EMD/2168) Antibody |
|||
| BNC052168-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against Emerin (Papillary Thyroid Carcinoma and EDMD Marker) (EMD/2168), CF405M conjugate, Concentration: 0.1mg/mL |
|||
Emerin (Papillary Thyroid Carcinoma and EDMD Marker) (EMD/2168) Antibody |
|||
| BNC052168-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against Emerin (Papillary Thyroid Carcinoma and EDMD Marker) (EMD/2168), CF405M conjugate, Concentration: 0.1mg/mL |
|||
Emerin (Papillary Thyroid Carcinoma and EDMD Marker) (EMD/2167) Antibody |
|||
| BNC432167-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against Emerin (Papillary Thyroid Carcinoma and EDMD Marker) (EMD/2167), CF543 conjugate, Concentration: 0.1mg/mL |
|||
Emerin (Papillary Thyroid Carcinoma and EDMD Marker) (EMD/2167) Antibody |
|||
| BNC432167-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against Emerin (Papillary Thyroid Carcinoma and EDMD Marker) (EMD/2167), CF543 conjugate, Concentration: 0.1mg/mL |
|||
Emerin (Papillary Thyroid Carcinoma and EDMD Marker) (EMD/2168) Antibody |
|||
| BNC432168-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against Emerin (Papillary Thyroid Carcinoma and EDMD Marker) (EMD/2168), CF543 conjugate, Concentration: 0.1mg/mL |
|||
Emerin (Papillary Thyroid Carcinoma and EDMD Marker) (EMD/2168) Antibody |
|||
| BNC432168-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against Emerin (Papillary Thyroid Carcinoma and EDMD Marker) (EMD/2168), CF543 conjugate, Concentration: 0.1mg/mL |
|||
Emerin (Papillary Thyroid Carcinoma and EDMD Marker) (EMD/2167) Antibody |
|||
| BNC612167-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against Emerin (Papillary Thyroid Carcinoma and EDMD Marker) (EMD/2167), CF660R conjugate, Concentration: 0.1mg/mL |
|||
Emerin (Papillary Thyroid Carcinoma and EDMD Marker) (EMD/2167) Antibody |
|||
| BNC612167-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against Emerin (Papillary Thyroid Carcinoma and EDMD Marker) (EMD/2167), CF660R conjugate, Concentration: 0.1mg/mL |
|||
Emerin (Papillary Thyroid Carcinoma and EDMD Marker) (EMD/2168) Antibody |
|||
| BNC612168-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against Emerin (Papillary Thyroid Carcinoma and EDMD Marker) (EMD/2168), CF660R conjugate, Concentration: 0.1mg/mL |
|||
Emerin (Papillary Thyroid Carcinoma and EDMD Marker) (EMD/2168) Antibody |
|||
| BNC612168-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against Emerin (Papillary Thyroid Carcinoma and EDMD Marker) (EMD/2168), CF660R conjugate, Concentration: 0.1mg/mL |
|||
Emerin (Papillary Thyroid Carcinoma and EDMD Marker) (EMD/2167) Antibody |
|||
| BNC812167-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against Emerin (Papillary Thyroid Carcinoma and EDMD Marker) (EMD/2167), CF680R conjugate, Concentration: 0.1mg/mL |
|||
Emerin (Papillary Thyroid Carcinoma and EDMD Marker) (EMD/2167) Antibody |
|||
| BNC812167-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against Emerin (Papillary Thyroid Carcinoma and EDMD Marker) (EMD/2167), CF680R conjugate, Concentration: 0.1mg/mL |
|||
Emerin (Papillary Thyroid Carcinoma and EDMD Marker) (EMD/2168) Antibody |
|||
| BNC812168-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against Emerin (Papillary Thyroid Carcinoma and EDMD Marker) (EMD/2168), CF680R conjugate, Concentration: 0.1mg/mL |
|||
Emerin (Papillary Thyroid Carcinoma and EDMD Marker) (EMD/2168) Antibody |
|||
| BNC812168-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against Emerin (Papillary Thyroid Carcinoma and EDMD Marker) (EMD/2168), CF680R conjugate, Concentration: 0.1mg/mL |
|||
Emerin (Papillary Thyroid Carcinoma and EDMD Marker) (EMD/2167) Antibody |
|||
| BNCP2167-250 | Biotium | 250uL | 472.8 EUR |
|
Description: Primary antibody against Emerin (Papillary Thyroid Carcinoma and EDMD Marker) (EMD/2167), PerCP conjugate, Concentration: 0.1mg/mL |
|||
Emerin (Papillary Thyroid Carcinoma and EDMD Marker) (EMD/2168) Antibody |
|||
| BNCP2168-250 | Biotium | 250uL | 472.8 EUR |
|
Description: Primary antibody against Emerin (Papillary Thyroid Carcinoma and EDMD Marker) (EMD/2168), PerCP conjugate, Concentration: 0.1mg/mL |
|||
Emerin (Papillary Thyroid Carcinoma and EDMD Marker) (EMD/2167) Antibody |
|||
| BNCR2167-250 | Biotium | 250uL | 472.8 EUR |
|
Description: Primary antibody against Emerin (Papillary Thyroid Carcinoma and EDMD Marker) (EMD/2167), RPE conjugate, Concentration: 0.1mg/mL |
|||